SEC Form 4 · accession 0000905148-26-003353
Opus Genetics, Inc. · IRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph K Schachle
Officer — Chief Operating Officer
Period of report
Jul 23, 2026
Accepted (ET)
Jul 27, 2026 · 4:07 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001228627
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 23, 2026 | S | 4,644 | $2.94 | D | 291,440 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.